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Abstract Stimulation of dopaminergic type 1 (D1) receptors
increases lung edema clearance by regulating Na,K-ATPase
function in the alveolar epithelium. We studied the role of serine/
threonine protein phosphatases in the Na,K-ATPase regulation
by D1 agonists in A549 cells. We found that low doses of the
type 1/2A protein phosphatase inhibitor okadaic acid as well as
SV40 small t antigen transiently transfected into A549 cells
prevented the D1 agonist-induced increase in Na,K-ATPase
activity and translocation from intracellular pools to the plasma
membrane. This was associated with a rapid and transient
increase in protein phosphatase 2A activity. We conclude that D1
stimulation regulates Na,K-ATPase activity by promoting
recruitment of Na,K-ATPases from intracellular pools into the
basolateral membranes of A549 cells via a type 2A protein
phosphatase. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The lung epithelium reabsorbs £uid from the alveolar space
by generating a sodium gradient with water following isos-
motically. Sodium enters the cells via apical sodium channels
and it is extruded through the basolaterally located Na,K-
ATPases [1^3]. The Na,K-ATPase is a membrane bound pro-
tein that establishes and maintains the intracellular high K
and low Na concentrations typical of mammalian cells by
hydrolyzing ATP. It is an oligomer composed of stoichomet-
ric amounts of two major polypeptides, the K- and the L-sub-
units [4]. Short-term regulation of Na,K-ATPase activity has
been demonstrated to increase the clearance of pulmonary
edema in rats [5^10]. Na,K-ATPase short-term regulation
may be a¡ected by changes in intracellular Na concentra-
tions, increased intracellular Na a⁄nity, translocation of
Na,K-ATPases from intracellular compartments to the plas-
ma membrane and/or phosphorylation^dephosphorylation re-
actions [4,11,12]. Recently, it has been described that Na,K-
ATPase translocation to the plasma membrane from intracel-
lular compartments is an important mechanism for Na,K-
ATPase regulation in rat alveolar epithelial cells [9,10].
The pathways regulating Na,K-ATPase tra⁄cking from in-
tracellular compartments to the plasma membrane have not
been well characterized. Serine/threonine protein phospha-
tases have been described to be important modulating the
secretory process [13] as well as mediating di¡erent transport-
ers translocation, such as the Na+/taurocholate cotransport
polypeptide [14]. The serine/threonine protein phosphatases
are usually classi¢ed into type 1 (PP1) or type 2 (PP2), de-
pending on their substrate speci¢city and sensitivity to inhib-
itors. Type 2 phosphatases are subdivided into three major
groups, including PP2A, calcium-dependent calcineurin
(PP2B) and magnesium-dependent PP2C [15]. PP2A, a pre-
dominant serine/threonine protein phosphatase in most mam-
malian tissues, has been implicated in the regulation of many
cellular processes including metabolism, transcription and cell
division (for recent review see [16]). PP2A is a target for DNA
tumor viruses including simian virus 40 (SV40) and binding of
SV40 small t antigen (small t) to PP2A results in its speci¢c
inhibition [17,18].
In the present study, using okadaic acid (OA) and SV40
small t antigen, we investigated the role of PP2A in the
Na,K-ATPase translocation induced by dopaminergic type 1
(D1) receptors in the human alveolar epithelial cell line A549.
2. Materials and methods
2.1. Materials
Percoll and [Q-32P]ATP were purchased from Amersham Pharmacia
(Piscataway, NJ, USA). OA was obtained from Calbiochem (La Jolla,
CA, USA). Fenoldopam (FEN) was a generous gift from Neurex
Pharmaceutical (Menlo Park, CA, USA). All other chemicals were
purchased from Sigma (St. Louis, MO, USA). The Na,K-ATPase
K1 antibody (clone 464.6) was a generous gift from Dr. M. Caplan
(Yale University). The plasmid containing the SV40 small t antigen
has been described elsewhere [19] and the CMV empty vector was a
gift from Dr. P. Factor (Northwestern University). The antibody
against SV40 small t antigen was purchased from Oncogene Science
(Uniondale, NY, USA).
2.2. Cell culture
A549 cells (ATCC CCL 185), a human adenocarcinoma cell line,
were grown in Dulbecco’s modi¢ed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum, 2 mM L-glutamine, 50 Wg/ml
gentamicin, 100 U/ml penicillin and 100 Wg/ml streptomycin. Cells
were incubated in a humidi¢ed atmosphere of 5% CO2/95% air at
37‡C, and fed twice a week. Cells were seeded in 10 cm plates and
grown to con£uence. Cells were starved 18^24 h before treatments.
2.3. Cell lysate and basolateral membrane isolation
Cells were treated with the di¡erent agonists/antagonists at 37‡C,
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placed on ice and washed twice with ice-cold phosphate-bu¡ered sa-
line (PBS). For cell lysates, cells were scraped in 1 ml lysis bu¡er
(20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM L-glycerol-
phosphate, 1 mM Na3VO4, 1 Wg/ml leupeptin, 1 mM PMSF; New
England Biolabs, Inc.) and centrifuged at 14 000Ug to eliminate all
the insoluble material. Basolateral membranes were obtained as de-
scribed before [5,9] using the technique described by Hammond et al.
[20]. Cells were scraped in PBS, centrifuged, resuspended in homoge-
nization bu¡er (300 mM mannitol in 12 mM Tris^HEPES, pH 7.6),
homogenized, and centrifuged twice to discard the nuclear and mito-
chondrial pellet. Supernatant was centrifuged at 48 000Ug for 30 min
and the basolateral membrane fraction was recovered after the mem-
brane pellet was centrifuged in a 16% Percoll gradient at 48 000Ug for
30 min.
2.4. Na,K-ATPase activity
Na,K-ATPase activity was determined in the basolateral plasma
membrane (BLM) fraction as described before [9,21]. Brie£y, 5^10
Wg protein were transferred to the Na,K-ATPase assay medium (¢nal
volume 100 Wl) containing in mM: NaCl 50, KCl 5, MgCl2 10, EGTA
1, Tris^HCl 50, Na2ATP 10 and [Q-32P]ATP in trace amounts. Cells
were transiently exposed to a cold shock (10 min at 320‡C) to render
membranes permeable to ATP. The samples were then incubated at
37‡C for 15 min, and the reaction was terminated by addition of
TCA/charcoal (5%/10% v/w) suspension and rapid cooling to 4‡C.
After separating the charcoal phase (12 000Ug for 5 min) containing
the unhydrolyzed nucleotide, the liberated 32P was counted in an
aliquot (200 Wl) from the supernatant. Na,K-ATPase activity was
calculated as the di¡erence between test samples (total ATPase activ-
ity) and samples assayed in the same medium, but devoid of Na and
K and in the presence of 2.5 mM ouabain. Non-speci¢c ATP hy-
drolysis was determined in samples in the absence of enzyme. The
speci¢c activity of the enzyme is expressed in nmol Pi/mg protein/h.
2.5. Western blot analysis
Protein was quanti¢ed by Bradford assay (Bio-Rad, Hercules, CA,
USA) and resolved in a 10% polyacrylamide gel. Thereafter, proteins
were transferred onto nitrocellulose membranes (Optitran, Schleicher
and Schuell, Keene, NH, USA) using a semi-dry transfer apparatus
(Bio-Rad, Hercules, CA, USA). Incubation with speci¢c antibodies
was performed overnight at 4‡C. Blots were developed with an en-
hanced chemiluminescence detection kit (ECL+, Amersham, Bucking-
hamshire, UK) used as recommended by the manufacturer. The bands
were quanti¢ed by densitometric scan (Eagle Eye II, Stratagene, La
Jolla, CA, USA).
2.6. Transient transfection
A549 cells were plated at a density of 5U105 cells in 6 cm plates,
and transient transfection was carried out with 5 Wg of the di¡erent
plasmids using lipofectin reagent (Life Technologies, Gaithersburg,
MD, USA). After 48 h, treatment was added, cells scraped and baso-
lateral membranes and cell lysates were obtained as described above.
2.7. PP2A assay
PP2A assay kits were purchased from Promega (Madison, WI,
USA). The assay is based on determining the amount of free phos-
phate generated in the reaction by measuring the absorbance of a
molybdate malachite green^phosphate complex. The assay was per-
formed on the membrane fraction obtained as the Triton X-100 solu-
ble fraction. Brie£y, 5 Wg of total membranes were incubated on a 96-
well plate together with a peptide substrate RRA(pT)VA and bu¡er
(50 mM imidazole, pH 7.2, 0.2 mM EGTA, 0.02% L-mercaptoetha-
nol, 0.1 mg/ml bovine serum albumin) for 30 min at 30‡C. After
incubation, the molybdate complex dye was added and incubated
for an additional 20 min at room temperature for color development.
The level of molybdate malachite green^phosphate complex formed
was monitored at 630 nm.
2.8. Statistical analysis
Data are represented as means þ S.E.M. When comparisons were
made between two experimental groups an unpaired Student’s t-test
was used. When multiple comparisons were made a one-way analysis
of variance was used, followed by a multiple comparison test (Tukey)
when the F statistic indicated signi¢cance. Results were considered
signi¢cant when P6 0.05.
3. Results and discussion
Recently it has been described that dopamine (via D1 type
receptors) stimulates sodium transport and edema clearance in
rat lung epithelium [7,8] via the regulation of Na,K-ATPase
activity [10]. The present study was designed to study the role
of serine/threonine protein phosphatases in the short-term ef-
fect of D1 agonists on Na,K-ATPase. We used A549 cells, a
cell line frequently employed in the study of alveolar epithelial
cell biology [22], which we have previously used to study
Na,K-ATPase function [23]. As shown in Fig. 1A, stimulation
with 10 WM of the D1 agonist FEN for 15 min increased
Na,K-ATPase activity in A549 cells. As depicted in Fig. 1B,
Na,K-ATPase translocated to the BLM from intracellular
compartments without changing the Na,K-ATPase K1-sub-
unit protein abundance in total cell lysates. These data suggest
that no de novo synthesis of protein occurred within the
15 min of treatment with FEN, but rather recruitment of
Fig. 1. E¡ect of D1 agonists in Na,K-ATPase activity and translo-
cation from intracellular pools. A549 cells were treated with 10 WM
FEN for 15 min and cell lysate and BLM isolation were carried out
as described in Section 2. A: Na,K-ATPase activity in the basolater-
al membrane. B: Western blots of cell lysates and BLM using an
antibody against the Na,K-ATPase K1-subunit. Graph represents
the mean þ S.E.M. of four di¡erent experiments. **P6 0.01,
***P6 0.001.
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preformed Na,K-ATPases from intracellular compartments
into the BLM, resulting in increased Na,K-ATPase activity.
Serine/threonine protein phosphatases have been shown to
play an important role in the regulation of secretory processes
[13] as well as in the translocation of transporters from intra-
cellular compartments to the plasma membrane [14]. PP1 and
PP2A are speci¢cally inhibited by a variety of naturally occur-
ring toxins such as OA [24]. OA potently inhibits both PP1
and PP2A, although with di¡erent sensitivities. PP1 has an
IC50 : 100^200 nM OA whereas PP2A has an IC50 : 0.3^1
nM OA [25]. OA has little or no e¡ect on PP2B or PP2C.
To determine whether PP1 or PP2A plays a role in Na,K-
ATPase stimulation induced by D1 agonists, we preincubated
A549 cells for 30 min with 500 nM OA before adding 10 WM
FEN. As shown in Fig. 2, preincubation with 500 nM OA
abolished the increase in Na,K-ATPase activity induced by
FEN (Fig. 2A), as well as the Na,K-ATPase translocation
to the BLM (Fig. 2B), suggesting a role for protein phospha-
tases in the regulation of Na,K-ATPase by D1 agonists.
To further examine whether PP2A had a role in the Na,K-
ATPase translocation induced by D1 agonists, A549 cells were
preincubated for 30 min with a low dose of OA (5 nM) before
adding 10 WM FEN for 15 min. As shown in Fig. 2, even 5 nM
OA inhibited the Na,K-ATPase activity (Fig. 2A) and trans-
location (Fig. 2B) from intracellular pools induced by FEN,
suggesting a role for PP2A. Thus, to better establish the in-
volvement of PP2A in the Na,K-ATPase regulation by D1
agonists, we tested the role of SV40 small t antigen transiently
transfected in A549 cells in the FEN-induced Na,K-ATPase
stimulation. As depicted in Fig. 3A, the transiently transfected
A549 cells expressed the SV40 small t antigen after 48 h,
whereas SV40 small t was not detected in cells transfected
with the empty vector. A549 cells transfected with the empty
vector had an increased Na,K-ATPase activity and K1-subunit
protein abundance in the BLM after 15 min of FEN treat-
ment. However, A549 cells transfected with the SV40 small t
antigen did not have increased Na,K-ATPase activity and K1-
subunit protein abundance in the BLMs in response to FEN
(Fig. 3B,C). These data strongly suggest that PP2A regulates
Fig. 2. E¡ect of OA in Na,K-ATPase activity and translocation in-
duced by D1 agonists. A549 cells were preincubated with 5 nM and
500 nM OA for 30 min before adding FEN for 15 min, and BLMs
were isolated as described in Section 2. A: Na,K-ATPase activity.
B: Western blot of BLMs using an antibody against the Na,K-
ATPase K1-subunit. Graphs represent the means þ S.E.M. of three
di¡erent experiments. **P6 0.01, ***P6 0.001.
Fig. 3. Small t prevents Na,K-ATPase activity and translocation in-
duced by D1 agonists. A549 cells were transiently transfected with
the SV40 small t antigen as described in Section 2 and the e¡ect of
FEN on Na,K-ATPase stimulation was studied. A: Representative
Western blot of A549 cell lysate using an antibody against small t.
B: Na,K-ATPase activity; graph represents the mean þ S.E.M. of
three di¡erent experiments. C: Representative Western blot of the
Na,K-ATPase K1-subunit in BLMs. *P6 0.05.
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the dopaminergic-induced Na,K-ATPase translocation to the
BLM.
To con¢rm that FEN-induced Na,K-ATPase stimulation in
A549 cells was associated with the activation of PP2A, we
performed a time-course of PP2A activity in cells treated
with FEN. As shown in Fig. 4, PP2A was transiently acti-
vated by FEN with peak activity at 1 min. The A549 mem-
brane fraction was used for measurement of PP2A activity as
suggested by a previous study, where a transient translocation
of PP2A to the membrane fraction after agonist stimulation
was required in the secretion process [13].
Similarly to many ion channels and cotransporters
[14,26,27], Na,K-ATPase activity can be modulated by phos-
phorylation/dephosphorylation reactions. Our ¢ndings are in
agreement with those of Blot-Chabaud et al. [28], where PP2A
regulated the vasopressin-induced Na,K-ATPase tra⁄cking in
the cortical collecting duct. However, recent reports suggest
PP1-mediated dephosphorylation of the Na,K-ATPase K1-
subunit [29,30] as the mechanism regulating the insulin acti-
vation of Na,K-ATPase function. The fact that di¡erent types
of protein phosphatases have been described to play a role in
Na,K-ATPase regulation demonstrate the complexity of the
signaling pathways that probably are receptor and cell type
speci¢c. There is also growing evidence suggesting an impor-
tant role for PP2A in protein tra⁄cking between cellular com-
partments such as in the microtubular transport [31,32] as well
as in endosome sorting [33].
In conclusion, our results, based on the experiments with
OA and small t, strongly suggest that PP2A is critically in-
volved in the dopaminergic-induced Na,K-ATPase transloca-
tion from intracellular compartments to the BLMs. Further
studies are warranted to elucidate the pathways and targets of
PP2A regulating the Na,K-ATPase cellular tra⁄cking.
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